Ablation Systems

This channel provides technology news on new ablation system advances in cardiac electrophysiology (EP) used to treat dysfunctional heart tissue that cause arrhythmias. Each cell in the myocardium generates its own electrical impulses to cause the heart to beat, but if some cells generate signals that are not in synch with other parts of the heart, it causes an arrhythmia, an abnormal heart beat. Ablation systems use heat (usually generated  by radio frequency, RF, energy or a laser) or extreme cold to cause small burns. These lesions create scar tissue that block electrical signals causing the arrhythmia. These procedures are guided by EP electro mapping systems

Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019

May 8, 2019 — Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new...

Acutus Medical Receives FDA Clearance for Second-generation AcQMap Platform
Technology | EP Mapping and Imaging Systems | April 26, 2019

April 26, 2019 — Acutus Medical announced U.S. Food and Drug Administration (FDA) clearance of its second-generation...

CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019

April 16, 2019 — CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic...

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019

The American College of Cardiology (ACC) released a list of the...

First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019

February 4, 2019 – Biosense Webster has enrolled and treated the first patient in its U.S....

Acutus AcQMap Imaging System Helps Eliminate Arrhythmia With Single Ablation
News | EP Mapping and Imaging Systems | January 28, 2019

January 28, 2019 — Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the...

FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019

January 21, 2019 — Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force...

Researchers raised the question whether an economic benefit should be assessed in FDA reviews. A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters.

A large amount of the bill for atrial fibrillation catheter ablation procedures is the cost of the mapping and ablation catheters. Researchers raised the question whether an economic benefit should be assessed in FDA reviews. 

Feature | Cardiovascular Business | January 14, 2019 | Philip Jacobs, DPhil, Ilke Akpinar, M.D., Thanh Nguyen, M.D., Ph.D., Rupinder Sandhu, M.D., and Lars Thording Ph.D.

In an age when everything in medicine is now looked at though a cost vs. benefit analysis and U.S. government...

Technology Improvements Driving Electrophysiology Market Growth

Navik 3D Cardiac Mapping System image courtesy of APN Health.

News | EP Lab | December 10, 2018

December 10, 2018 — Electrophysiology,...

First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018

November 30, 2018 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has...

First Carto Vizigo Bi-Directional Guiding Sheath Employed on West Coast
News | EP Mapping and Imaging Systems | October 29, 2018

October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto...

FDA Approves Biosense Webster's Tag-Index Guided Ablation Software
Technology | Ablation Systems | October 09, 2018

October 9, 2018 — Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA)...

Overlay Init